{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:48:31Z","timestamp":1760906911520},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.ygyno.2007.07.048","type":"journal-article","created":{"date-parts":[[2007,9,4]],"date-time":"2007-09-04T12:42:51Z","timestamp":1188909771000},"page":"S5-S7","source":"Crossref","is-referenced-by-count":5,"special_numbering":"S","title":["HPV testing in the follow-up after treatment of women with CIN"],"prefix":"10.1016","volume":"107","author":[{"given":"Helmut","family":"von Keyserling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas M.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achim","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2007.07.048_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.ygyno.2007.07.048_bib2","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc798","article-title":"Papillomaviruses and cancer: from basic studies to clinical application","volume":"2","author":"zur Hausen","year":"2002","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2007.07.048_bib3","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1471-0528.1997.tb11983.x","article-title":"A study of treatment failures following large loop excision of the transformation zone for the treatment of cervical intraepithelial neoplasia","volume":"104","author":"Flannelly","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"issue":"9057","key":"10.1016\/j.ygyno.2007.07.048_bib4","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0140-6736(96)08295-5","article-title":"Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia","volume":"349","author":"Soutter","year":"1997","journal-title":"Lancet"},{"issue":"3 Suppl 1","key":"10.1016\/j.ygyno.2007.07.048_bib5","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.ygyno.2005.07.033","article-title":"Clinical utility of HPV\u2013DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence","volume":"99","author":"Arbyn","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"Suppl 3","key":"10.1016\/j.ygyno.2007.07.048_bib6","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.vaccine.2006.05.117","article-title":"Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses","volume":"24","author":"Arbyn","year":"2006","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.ygyno.2007.07.048_bib7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejogrb.2004.06.029","article-title":"Role of human papillomavirus (HPV) testing in the follow-up of patients after treatment for cervical precancerous lesions","volume":"118","author":"Hernadi","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5 Pt 1","key":"10.1016\/j.ygyno.2007.07.048_bib8","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0029-7844(01)01535-6","article-title":"Human papillomavirus testing and the outcome of treatment for cervical intraepithelial neoplasia","volume":"98","author":"Paraskevaidis","year":"2001","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ygyno.2007.07.048_bib9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ygyno.2006.10.011","article-title":"HPV16 and increased risk of recurrence after treatment for CIN","volume":"104","author":"Murat","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2007.07.048_bib10","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00004347-199304000-00018","article-title":"Natural history of cervical intraepithelial neoplasia: a critical review","volume":"12","author":"Ostor","year":"1993","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"10.1016\/j.ygyno.2007.07.048_bib11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1006\/gyno.2001.6336","article-title":"The significance of human papillomavirus viral load in prediction of histologic severity and size of squamous intraepithelial lesions of uterine cervix","volume":"83","author":"Sun","year":"2001","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ygyno.2007.07.048_bib12","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/ijc.10232","article-title":"Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II\/III and viral clearance","volume":"98","author":"van Duin","year":"2002","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2007.07.048_bib13","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/ijc.21477","article-title":"Cross-sectional analysis of oncogenic HPV viral load and cervical intraepithelial neoplasia","volume":"118","author":"Flores","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2007.07.048_bib14","first-page":"6132","article-title":"Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes","volume":"59","author":"Klaes","year":"1999","journal-title":"Cancer Res"},{"issue":"23","key":"10.1016\/j.ygyno.2007.07.048_bib15","doi-asserted-by":"crossref","first-page":"12762","DOI":"10.1128\/JVI.78.23.12762-12772.2004","article-title":"Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia","volume":"78","author":"Kalantari","year":"2004","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.ygyno.2007.07.048_bib16","first-page":"241","article-title":"Correlation of immuno-chemical detection of HPV L1 capsid protein in pap smears with regression of high-risk HPV positive mild\/moderate CIN","volume":"26","author":"Griesser","year":"2004","journal-title":"Anal Quant Cytol Histol"},{"issue":"6","key":"10.1016\/j.ygyno.2007.07.048_bib17","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/ijc.20839","article-title":"Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: a 2-year follow-up of women with ASCUS or LSIL Pap smear","volume":"10;114","author":"Molden","year":"2005","journal-title":"Int J Cancer"},{"issue":"8","key":"10.1016\/j.ygyno.2007.07.048_bib18","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1002\/ijc.22060","article-title":"Assessment of gene promoter hypermethylation for detection of cervical neoplasia","volume":"119","author":"Wisman","year":"2006","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2007.07.048_bib19","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/sj.onc.1205073","article-title":"Analysis of telomerase as a diagnostic biomarker of cervical CIN and carcinoma","volume":"21","author":"Jarboe","year":"2002","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.ygyno.2007.07.048_bib20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/01.pgp.0000209573.54457.32","article-title":"Over-expression of topoisomerase IIalpha is related to the grade of cervical intraepithelial neoplasia (CIN) and high-risk human papillomavirus (HPV), but does not predict prognosis in cervical cancer or HPV clearance after cone treatment","volume":"25","author":"Branca","year":"2006","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ygyno.2007.07.048_bib21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/jcp.2004.018895","article-title":"p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer","volume":"58","author":"Murphy","year":"2005","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ygyno.2007.07.048_bib22","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1158\/1055-9965.EPI-03-0166","article-title":"Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa Rica","volume":"13","author":"Viscidi","year":"2004","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.ygyno.2007.07.048_bib23","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0140-6736(06)68439-0","article-title":"Sustained efficacy up to 4.5\u00a0years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial","volume":"367","author":"Harper","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2007.07.048_bib24","unstructured":"US Food and Drug Administration. Product Approval Information-Licensing Action: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine. Available at: http:\/\/www.fda.gov\/cber\/products\/hpvmer060806.htm. Accessed October 26, 2006."},{"key":"10.1016\/j.ygyno.2007.07.048_bib25","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00001622-200409000-00013","article-title":"Vaccination strategies for the treatment and prevention of cervical cancer","volume":"16","author":"Schreckenberger","year":"2004","journal-title":"Curr Opin Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825807005239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825807005239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T21:20:07Z","timestamp":1546636807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825807005239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0090825807005239"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2007.07.048","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}